Obesity clinical trials in Connecticut
24 studies for Obesity are looking for participants at sites in Connecticut.
Cities in Connecticut
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Yale University, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351045Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Chase Medical Research, Waterbury
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07685808A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- CMR of Greater New Haven, LLC, Hamden
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07843498Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
- Yale Stress Center, New Haven
- Yale Stress Center, New Haven
RecruitingPhase 1
Ages 18 to 68 · All sexes · Updated Nov 4, 2026 · NCT07772960Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Yale New Haven Children's Hospital, New Haven
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Nov 4, 2026 · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- New England Research Associates, LLC, Bridgeport
- CMR of Greater New Haven, LLC, Hamden
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- New England Research Associates, LLC, Bridgeport
- Yale University School of Medicine, New Haven
- Chase Medical Research, LLC, Waterbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07392190A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Yale School of Medicine - Yale Diabetes Center (YDC)) Trials, New Haven
- Stamford Therapeutics Consortium, Stamford
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Nov 4, 2026 · NCT06672549Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions
- University of Connecticut, Storrs
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 3, 2026 · NCT06393725A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Bridgeport
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Cardiology Associates of Fairfield County PC, Stamford
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 29, 2026 · NCT07037459Investigation of Egg Intake and the Relationship Between Gut Microbiome, Metabolic, and Immune Profiles
- University of Connecticut, Storrs
RecruitingHealthy volunteers welcome
Ages 18 to 50 · All sexes · Updated Oct 22, 2026 · NCT07844616A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Waterbury
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Oct 20, 2026 · NCT07654374A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
- UConn Health, Farmington
- Hartford HealthCare, Hartford
- University of Connecticut, Storrs
Recruiting
Ages 18 to 64 · All sexes · Updated Oct 16, 2026 · NCT07238556A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Stamford Therapeutics Consortium, Stamford
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 8, 2026 · NCT07589608A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Stamford Therapeutics Consortium, Stamford
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 7, 2026 · NCT06143956Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Chase Medical Research LLC, Waterbury
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 5, 2026 · NCT07684235A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Chase Medical Research, LLC, Waterbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07321886AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Chase Medical Research LLC, Waterbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07509307Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
- Hartford HealthCare, Hartford
Recruiting
Ages 18 to 64 · All sexes · Updated Aug 6, 2026 · NCT06484621Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
- Yale Pediatric Diabetes Center, Adult and Children's Progam, New Haven
RecruitingPhase 2
Ages 18 to 30 · All sexes · Updated Aug 4, 2026 · NCT06411210A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Chase Medical Research LLC, Hamden
- Chase Medical Research LLC, Waterbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07481630New Mechanisms of Obesity
- Yale University, New Haven
Recruiting
Ages 15 to 22 · All sexes · Updated Jan 28, 2026 · NCT06768827Craving Network Neurofeedback
- Yale MRRC Anlyan Center, New Haven
RecruitingHealthy volunteers welcome
Ages 18 to 60 · All sexes · Updated Dec 3, 2025 · NCT06426693From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.